Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants - Hehlmann, Rüdiger; Saußele, Susanne; Fabarius, Alice; Kohlbrenner, Katharina; Voskanyan, Astghik; Rinaldetti, Sébastien; Seifarth, Wolfgang; Spiess, Birgit; Ho, Anthony Dick (Leukemia, 2017)
Advance online publication, 12 September 2017